Midazolam Accord Stungulyf/innrennslislyf, lausn 5 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

midazolam accord stungulyf/innrennslislyf, lausn 5 mg/ml

accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 5 mg/ml

Midazolam Accord Stungulyf/innrennslislyf, lausn 1 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

midazolam accord stungulyf/innrennslislyf, lausn 1 mg/ml

accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 1 mg/ml

HorStem Європейський Союз - ісландська - EMA (European Medicines Agency)

horstem

equicord s.l. - hrossum naflastrenginn mesenchymal stofnfrumur - Önnur lyf við sjúkdómum í stoðkerfi - hestar - lækkun helti tengslum við vægt til í meðallagi hrörnunar sameiginlega sjúkdómur (university of) í hestar.

Zinforo Європейський Союз - ісландська - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - sýklalyf fyrir almenn nota, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

Rapilysin Європейський Союз - ісландська - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplasa - hjartadrep - blóðþurrðandi lyf - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Ytracis Європейський Союз - ісландська - EMA (European Medicines Agency)

ytracis

cis bio international - yttrium (90y) chloride - radionuclide imaging - greining geislavirkja - aðeins má nota til geislamerktar flutningsfrumeindanna sem hafa verið sérstaklega þróuð og leyfð til geislamerktar með þessu radionuklíði. radiopharmaceutical precursor - not intended for direct application to patients.

Improvac Європейський Союз - ісландська - EMA (European Medicines Agency)

improvac

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - Ónæmissjúkdómar fyrir suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. einnig er hægt að minnka annan lykilframlag í söguna, skatole, sem óbein áhrif. Árásargjarn og kynferðisleg (uppbyggjandi) hegðun er einnig minni. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).